This can support weight loss, better glycemic control, and overall metabolic health
Glucagon-like peptide-1 (GLP-1)-based obesity treatments, which stimulate and suppress the secretion of the blood sugar-regulating hormones insulin and glucagon, respectively, were first approved by the U.S
Understanding the mechanism of action Together, sitagliptin and metformin help lower blood sugar levels more effectively than either medication alone, especially after meals
Depending on your needs, your provider may prescribe a maximum daily dose of up to 1.8 milligrams
For instance, in the STEP 4 trial, participants who discontinued Wegovy after 20 weeks regained approximately 70% of the weight they had lost within 48 weeks